May 2022

Rimegepant, a medication indicated for acute migraine relief, also may be efficacious as a preventive therapy by reducing the number of days per month that patients experience migraine.

The safety profile for diazepam nasal spray for acute treatment of seizure clusters was similar with or without concomitant benzodiazepine therapy, according to the interim results of a phase 3 open-label safety study.

An investigational drug for postpartum depression was associated with improvements in core symptoms of depression and maternal functioning.

In patients with type 2 diabetes, a younger age of onset is associated with an increased risk of developing dementia.